"Novartis will reimburse Mesoblast up to US$50 million on the achievement of certain milestones related tothe successful implementation of its next-generation manufacturing processes using its proprietary media and three-dimensional bioreactors aimed at delivering substantial manufacturing efficiencies"
I hope Novartis put a timetable on the 3D bioreactors for their milestone payments, otherwise they might be in for a long wait. These reactors have been a pipedream work in progress for MSB for the last 5 or 6 years.
Does anyone else have an inkling that this could have something to do with the recent joint announcement by Fujifilm and Lonza (MSB's CDMO) to collaborate on iPSC technology?
Mesoblast and Novartis collaboration, page-6
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $49.39M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.5¢ | $6.183K | 22.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 32514 | 3 |
View Market Depth
| Last trade - 11.18am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
0.005 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 28.0¢ | 27.0¢ | 21201 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| CYP (ASX) Chart |